Skip to main content
Erschienen in: Infection 1/2014

01.02.2014 | Clinical and Epidemiological Study

Antibiotic stewardship in Germany: a cross-sectional questionnaire survey of 355 intensive care units

verfasst von: F. Maechler, F. Schwab, C. Geffers, E. Meyer, R. Leistner, P. Gastmeier

Erschienen in: Infection | Ausgabe 1/2014

Einloggen, um Zugang zu erhalten

Abstract

Purpose

Little information is available on antibiotic prescription management in German hospitals. The objective of this cross-sectional study was to determine the prevalence and components of antibiotic stewardship measures in German intensive care units (ICUs).

Methods

A questionnaire survey was sent to all ICUs participating in the German nosocomial infection surveillance system (n = 579) in October 2011. Data on antibiotic management structures were collected and analyzed by structural hospital and ICU factors.

Results

The questionnaire was completed by 355 German ICUs (response rate 61 %). Common measures used (>80 % of the ICUs) were personnel restrictions for antibiotic prescriptions, routine access to bacterial resistance data, and pharmacy reports on antibiotic costs and consumption. A small proportion of ICUs (14 %) employed physicians specialized in the prescription of antimicrobial medication. Hospitals with their own microbiological laboratory report participation in surveillance networks for antimicrobial use (34 %) and bacterial resistance (32 %) twice as often as hospitals with external laboratories (15 and 14 %, respectively, p < 0.001). Also, non-profit and public hospitals participate more often in surveillance networks for bacterial resistance than private hospitals (>23 % vs. 11 %, p < 0.05).

Conclusions

While the majority of ICUs report to have some antibiotic policies established, the contents and composition of these policies vary. Organizational-level control strategies to improve antibiotic management are common in Germany. However, strategies widely considered effective, such as the systematic cross-institutional surveillance of antimicrobial use and bacterial resistance in a standardized manner or the employment of infectious disease specialists, are scarce. This study provides a benchmark for future antibiotic stewardship programs.
Anhänge
Nur mit Berechtigung zugänglich
Literatur
1.
Zurück zum Zitat Davey P, Brown E, Charani E, Fenelon L, Gould IM, Holmes A, et al. Interventions to improve antibiotic prescribing practices for hospital inpatients. Cochrane Database Syst Rev. 2013;4:CD003543.PubMed Davey P, Brown E, Charani E, Fenelon L, Gould IM, Holmes A, et al. Interventions to improve antibiotic prescribing practices for hospital inpatients. Cochrane Database Syst Rev. 2013;4:CD003543.PubMed
2.
Zurück zum Zitat Paskovaty A, Pflomm JM, Myke N, Seo SK. A multidisciplinary approach to antimicrobial stewardship: evolution into the 21st century. Int J Antimicrob Agents. 2005;25:1–10.PubMedCrossRef Paskovaty A, Pflomm JM, Myke N, Seo SK. A multidisciplinary approach to antimicrobial stewardship: evolution into the 21st century. Int J Antimicrob Agents. 2005;25:1–10.PubMedCrossRef
3.
Zurück zum Zitat Wagenlehner FM, Hoyme U, Kaase M, Fünfstück R, Naber KG, Schmiemann G. Uncomplicated urinary tract infections. Dtsch Arztebl Int. 2011;108:415–23.PubMedCentralPubMed Wagenlehner FM, Hoyme U, Kaase M, Fünfstück R, Naber KG, Schmiemann G. Uncomplicated urinary tract infections. Dtsch Arztebl Int. 2011;108:415–23.PubMedCentralPubMed
4.
Zurück zum Zitat Mandell LA, Wunderink RG, Anzueto A, Bartlett JG, Campbell GD, Dean NC, et al. Infectious Diseases Society of America/American Thoracic Society consensus guidelines on the management of community-acquired pneumonia in adults. Clin Infect Dis. 2007;44:S27–72.PubMedCrossRef Mandell LA, Wunderink RG, Anzueto A, Bartlett JG, Campbell GD, Dean NC, et al. Infectious Diseases Society of America/American Thoracic Society consensus guidelines on the management of community-acquired pneumonia in adults. Clin Infect Dis. 2007;44:S27–72.PubMedCrossRef
5.
Zurück zum Zitat Hohmann C, Eickhoff C, Radziwill R, Schulz M. Adherence to guidelines for antibiotic prophylaxis in surgery patients in German hospitals: a multicentre evaluation involving pharmacy interns. Infection. 2012;40:131–7.PubMedCrossRef Hohmann C, Eickhoff C, Radziwill R, Schulz M. Adherence to guidelines for antibiotic prophylaxis in surgery patients in German hospitals: a multicentre evaluation involving pharmacy interns. Infection. 2012;40:131–7.PubMedCrossRef
6.
Zurück zum Zitat van der Velden LB, Tromp M, Bleeker-Rovers CP, Hulscher M, Kullberg BJ, Mouton JW, et al. Non-adherence to antimicrobial treatment guidelines results in more broad-spectrum but not more appropriate therapy. Eur J Clin Microbiol Infect Dis. 2012;31:1561–8.PubMedCentralPubMedCrossRef van der Velden LB, Tromp M, Bleeker-Rovers CP, Hulscher M, Kullberg BJ, Mouton JW, et al. Non-adherence to antimicrobial treatment guidelines results in more broad-spectrum but not more appropriate therapy. Eur J Clin Microbiol Infect Dis. 2012;31:1561–8.PubMedCentralPubMedCrossRef
7.
Zurück zum Zitat George P, Morris AM. Pro/con debate: Should antimicrobial stewardship programs be adopted universally in the intensive care unit? Crit Care. 2010;14:205.PubMedCrossRef George P, Morris AM. Pro/con debate: Should antimicrobial stewardship programs be adopted universally in the intensive care unit? Crit Care. 2010;14:205.PubMedCrossRef
9.
Zurück zum Zitat Dellit TH, Owens RC, McGowan JE Jr, Gerding DN, Weinstein RA, Burke JP, et al. Infectious Diseases Society of America and the Society for Healthcare Epidemiology of America guidelines for developing an institutional program to enhance antimicrobial stewardship. Clin Infect Dis. 2007;44:159–77.PubMedCrossRef Dellit TH, Owens RC, McGowan JE Jr, Gerding DN, Weinstein RA, Burke JP, et al. Infectious Diseases Society of America and the Society for Healthcare Epidemiology of America guidelines for developing an institutional program to enhance antimicrobial stewardship. Clin Infect Dis. 2007;44:159–77.PubMedCrossRef
10.
Zurück zum Zitat Pope SD, Dellit TH, Owens RC, Hooton TM. Results of survey on implementation of Infectious Diseases Society of America and Society for Healthcare Epidemiology of America guidelines for developing an institutional program to enhance antimicrobial stewardship. Infect Control Hosp Epidemiol. 2009;30:97–8.PubMedCrossRef Pope SD, Dellit TH, Owens RC, Hooton TM. Results of survey on implementation of Infectious Diseases Society of America and Society for Healthcare Epidemiology of America guidelines for developing an institutional program to enhance antimicrobial stewardship. Infect Control Hosp Epidemiol. 2009;30:97–8.PubMedCrossRef
11.
Zurück zum Zitat Prins JM, Degener JE, de Neeling AJ, Gyssens IC. Experiences with the Dutch Working Party on antibiotic policy (SWAB). Euro Surveill. 2008;13. pii: 19037. Prins JM, Degener JE, de Neeling AJ, Gyssens IC. Experiences with the Dutch Working Party on antibiotic policy (SWAB). Euro Surveill. 2008;13. pii: 19037.
12.
Zurück zum Zitat Kern WV, Steib-Bauert M, Amann S, Fellhauer M, de With K. Hospital antibiotic management in Germany—results of the ABS maturity survey of the ABS International group. Wien Klin Wochenschr. 2008;120:294–8.PubMedCrossRef Kern WV, Steib-Bauert M, Amann S, Fellhauer M, de With K. Hospital antibiotic management in Germany—results of the ABS maturity survey of the ABS International group. Wien Klin Wochenschr. 2008;120:294–8.PubMedCrossRef
13.
Zurück zum Zitat Gastmeier P, Sohr D, Schwab F, Behnke M, Zuschneid I, Brandt C, et al. Ten years of KISS: the most important requirements for success. J Hosp Infect. 2008;70:11–6.PubMedCrossRef Gastmeier P, Sohr D, Schwab F, Behnke M, Zuschneid I, Brandt C, et al. Ten years of KISS: the most important requirements for success. J Hosp Infect. 2008;70:11–6.PubMedCrossRef
14.
Zurück zum Zitat Meyer E, Sohr D, Gastmeier P, Geffers C. New identification of outliers and ventilator-associated pneumonia rates from 2005 to 2007 within the German Nosocomial Infection Surveillance System. J Hosp Infect. 2009;73:246–52.PubMedCrossRef Meyer E, Sohr D, Gastmeier P, Geffers C. New identification of outliers and ventilator-associated pneumonia rates from 2005 to 2007 within the German Nosocomial Infection Surveillance System. J Hosp Infect. 2009;73:246–52.PubMedCrossRef
17.
Zurück zum Zitat Critchley IA, Karlowsky JA. Optimal use of antibiotic resistance surveillance systems. Clin Microbiol Infect. 2004;10:502–11.PubMedCrossRef Critchley IA, Karlowsky JA. Optimal use of antibiotic resistance surveillance systems. Clin Microbiol Infect. 2004;10:502–11.PubMedCrossRef
18.
Zurück zum Zitat Larson EL, Quiros D, Giblin T, Lin S. Relationship of antimicrobial control policies and hospital and infection control characteristics to antimicrobial resistance rates. Am J Crit Care. 2007;16:110–20.PubMedCentralPubMed Larson EL, Quiros D, Giblin T, Lin S. Relationship of antimicrobial control policies and hospital and infection control characteristics to antimicrobial resistance rates. Am J Crit Care. 2007;16:110–20.PubMedCentralPubMed
19.
Zurück zum Zitat Meyer E, Gastmeier P. Surveillance of antibiotic use and resistance. Anasthesiol Intensivmed Notfallmed Schmerzther. 2007;42:116–20.PubMedCrossRef Meyer E, Gastmeier P. Surveillance of antibiotic use and resistance. Anasthesiol Intensivmed Notfallmed Schmerzther. 2007;42:116–20.PubMedCrossRef
20.
Zurück zum Zitat Carbonne A, Arnaud I, Maugat S, Marty N, Dumartin C, Bertrand X, et al. National multidrug-resistant bacteria (MDRB) surveillance in France through the RAISIN network: a 9 year experience. J Antimicrob Chemother. 2013;68:954–9.PubMedCrossRef Carbonne A, Arnaud I, Maugat S, Marty N, Dumartin C, Bertrand X, et al. National multidrug-resistant bacteria (MDRB) surveillance in France through the RAISIN network: a 9 year experience. J Antimicrob Chemother. 2013;68:954–9.PubMedCrossRef
21.
Zurück zum Zitat Fridkin SK, Lawton R, Edwards JR, Tenover FC, McGowan JE Jr, Gaynes RP. Monitoring antimicrobial use and resistance: comparison with a national benchmark on reducing vancomycin use and vancomycin-resistant enterococci. Emerg Infect Dis. 2002;8:702–7.PubMedCrossRef Fridkin SK, Lawton R, Edwards JR, Tenover FC, McGowan JE Jr, Gaynes RP. Monitoring antimicrobial use and resistance: comparison with a national benchmark on reducing vancomycin use and vancomycin-resistant enterococci. Emerg Infect Dis. 2002;8:702–7.PubMedCrossRef
22.
Zurück zum Zitat Chaberny IF, Wriggers A, Behnke M, Gastmeier P. Antibiotics: MRSA prevention measures in German hospitals: results of a survey among hospitals, performed as part of the MRSA-KISS module. Dtsch Arztebl Int. 2010;107:631–7.PubMedCentralPubMed Chaberny IF, Wriggers A, Behnke M, Gastmeier P. Antibiotics: MRSA prevention measures in German hospitals: results of a survey among hospitals, performed as part of the MRSA-KISS module. Dtsch Arztebl Int. 2010;107:631–7.PubMedCentralPubMed
23.
Zurück zum Zitat Kuster SP, Ruef C, Ledergerber B, Hintermann A, Deplazes C, Neuber L, et al. Quantitative antibiotic use in hospitals: comparison of measurements, literature review, and recommendations for a standard of reporting. Infection. 2008;36:549–59.PubMedCrossRef Kuster SP, Ruef C, Ledergerber B, Hintermann A, Deplazes C, Neuber L, et al. Quantitative antibiotic use in hospitals: comparison of measurements, literature review, and recommendations for a standard of reporting. Infection. 2008;36:549–59.PubMedCrossRef
24.
Zurück zum Zitat KRINKO. Surveillance nosokomialer Infektionen sowie die Erfassung von Erregern mit speziellen Resistenzen und Multiresistenzen § 6 Abs. 3 und § 23 Abs. 1 und 2 in Verbindung mit § 4 Abs.2 Nr. 2b IfSG. Rechtliche Voraussetzungen und Umsetzungsempfehlungen. Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz. 2000;43:887–90.CrossRef KRINKO. Surveillance nosokomialer Infektionen sowie die Erfassung von Erregern mit speziellen Resistenzen und Multiresistenzen § 6 Abs. 3 und § 23 Abs. 1 und 2 in Verbindung mit § 4 Abs.2 Nr. 2b IfSG. Rechtliche Voraussetzungen und Umsetzungsempfehlungen. Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz. 2000;43:887–90.CrossRef
25.
Zurück zum Zitat KRINKO. Surveillance nosokomialer Infektionen sowie die Erfassung von Krankheits-erregern mit speziellen Resistenzen und Multiresistenzen. Fortschreibung der Liste der gemäß §4 Abs. 2 Nr.2 Buchstabe b in Verbindung mit §23 Abs.4 IfSG zu erfassenden nosokomialen Infektionen und Krankheitserreger mit speziellen Resistenzen und Multiresistenzen. Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz. 2013;56:580–3.CrossRef KRINKO. Surveillance nosokomialer Infektionen sowie die Erfassung von Krankheits-erregern mit speziellen Resistenzen und Multiresistenzen. Fortschreibung der Liste der gemäß §4 Abs. 2 Nr.2 Buchstabe b in Verbindung mit §23 Abs.4 IfSG zu erfassenden nosokomialen Infektionen und Krankheitserreger mit speziellen Resistenzen und Multiresistenzen. Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz. 2013;56:580–3.CrossRef
26.
Zurück zum Zitat Ivers N, Jamtvedt G, Flottorp S, Young JM, Odgaard-Jensen J, French SD, et al. Audit and feedback: effects on professional practice and healthcare outcomes. Cochrane Database Syst Rev. 2012;6:CD000259.PubMed Ivers N, Jamtvedt G, Flottorp S, Young JM, Odgaard-Jensen J, French SD, et al. Audit and feedback: effects on professional practice and healthcare outcomes. Cochrane Database Syst Rev. 2012;6:CD000259.PubMed
27.
Zurück zum Zitat Woodward RS, Medoff G, Smith MD, Gray JL 3rd. Antibiotic cost savings from formulary restrictions and physician monitoring in a medical-school-affiliated hospital. Am J Med. 1987;83:817–23.PubMedCrossRef Woodward RS, Medoff G, Smith MD, Gray JL 3rd. Antibiotic cost savings from formulary restrictions and physician monitoring in a medical-school-affiliated hospital. Am J Med. 1987;83:817–23.PubMedCrossRef
28.
Zurück zum Zitat Frank MO, Batteiger BE, Sorensen SJ, Hartstein AI, Carr JA, McComb JS, et al. Decrease in expenditures and selected nosocomial infections following implementation of an antimicrobial-prescribing improvement program. Clin Perform Qual Health Care. 1997;5:180–8.PubMed Frank MO, Batteiger BE, Sorensen SJ, Hartstein AI, Carr JA, McComb JS, et al. Decrease in expenditures and selected nosocomial infections following implementation of an antimicrobial-prescribing improvement program. Clin Perform Qual Health Care. 1997;5:180–8.PubMed
29.
Zurück zum Zitat John JF Jr, Fishman NO. Programmatic role of the infectious diseases physician in controlling antimicrobial costs in the hospital. Clin Infect Dis. 1997;24:471–85.PubMedCrossRef John JF Jr, Fishman NO. Programmatic role of the infectious diseases physician in controlling antimicrobial costs in the hospital. Clin Infect Dis. 1997;24:471–85.PubMedCrossRef
30.
Zurück zum Zitat McGowan JE Jr. Do intensive hospital antibiotic control programs prevent the spread of antibiotic resistance? Infect Control Hosp Epidemiol. 1994;15:478–83.PubMedCrossRef McGowan JE Jr. Do intensive hospital antibiotic control programs prevent the spread of antibiotic resistance? Infect Control Hosp Epidemiol. 1994;15:478–83.PubMedCrossRef
31.
Zurück zum Zitat Gould IM. A review of the role of antibiotic policies in the control of antibiotic resistance. J Antimicrob Chemother. 1999;43:459–65.PubMedCrossRef Gould IM. A review of the role of antibiotic policies in the control of antibiotic resistance. J Antimicrob Chemother. 1999;43:459–65.PubMedCrossRef
32.
Zurück zum Zitat Cooke FJ, Choubina P, Holmes AH. Postgraduate training in infectious diseases: investigating the current status in the international community. Lancet Infect Dis. 2005;5:440–9.PubMedCrossRef Cooke FJ, Choubina P, Holmes AH. Postgraduate training in infectious diseases: investigating the current status in the international community. Lancet Infect Dis. 2005;5:440–9.PubMedCrossRef
33.
Zurück zum Zitat Schweickert B, Kern WV, de With K, Meyer E, Berner R, Kresken M, et al. Surveillance of antibiotic consumption: Clarification of the “definition of data on the nature and extent of antibiotic consumption in hospitals according to section sign 23 paragraph 4 sentence 2 of the IfSG”. Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz. 2013;56:903–12.PubMedCrossRef Schweickert B, Kern WV, de With K, Meyer E, Berner R, Kresken M, et al. Surveillance of antibiotic consumption: Clarification of the “definition of data on the nature and extent of antibiotic consumption in hospitals according to section sign 23 paragraph 4 sentence 2 of the IfSG”. Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz. 2013;56:903–12.PubMedCrossRef
34.
Zurück zum Zitat Bruce J, MacKenzie FM, Cookson B, Mollison J, van der Meer JW, Krcmery V, et al. Antibiotic stewardship and consumption: findings from a pan-European hospital study. J Antimicrob Chemother. 2009;64:853–60.PubMedCrossRef Bruce J, MacKenzie FM, Cookson B, Mollison J, van der Meer JW, Krcmery V, et al. Antibiotic stewardship and consumption: findings from a pan-European hospital study. J Antimicrob Chemother. 2009;64:853–60.PubMedCrossRef
35.
Zurück zum Zitat Zoutman DE, Ford BD. The relationship between hospital infection surveillance and control activities and antibiotic-resistant pathogen rates. Am J Infect Control. 2005;33:1–5.PubMedCrossRef Zoutman DE, Ford BD. The relationship between hospital infection surveillance and control activities and antibiotic-resistant pathogen rates. Am J Infect Control. 2005;33:1–5.PubMedCrossRef
Metadaten
Titel
Antibiotic stewardship in Germany: a cross-sectional questionnaire survey of 355 intensive care units
verfasst von
F. Maechler
F. Schwab
C. Geffers
E. Meyer
R. Leistner
P. Gastmeier
Publikationsdatum
01.02.2014
Verlag
Springer Berlin Heidelberg
Erschienen in
Infection / Ausgabe 1/2014
Print ISSN: 0300-8126
Elektronische ISSN: 1439-0973
DOI
https://doi.org/10.1007/s15010-013-0531-y

Weitere Artikel der Ausgabe 1/2014

Infection 1/2014 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Triglyzeridsenker schützt nicht nur Hochrisikopatienten

10.05.2024 Hypercholesterinämie Nachrichten

Patienten mit Arteriosklerose-bedingten kardiovaskulären Erkrankungen, die trotz Statineinnahme zu hohe Triglyzeridspiegel haben, profitieren von einer Behandlung mit Icosapent-Ethyl, und zwar unabhängig vom individuellen Risikoprofil.

Gibt es eine Wende bei den bioresorbierbaren Gefäßstützen?

In den USA ist erstmals eine bioresorbierbare Gefäßstütze – auch Scaffold genannt – zur Rekanalisation infrapoplitealer Arterien bei schwerer PAVK zugelassen worden. Das markiert einen Wendepunkt in der Geschichte dieser speziellen Gefäßstützen.

Vorsicht, erhöhte Blutungsgefahr nach PCI!

10.05.2024 Koronare Herzerkrankung Nachrichten

Nach PCI besteht ein erhöhtes Blutungsrisiko, wenn die Behandelten eine verminderte linksventrikuläre Ejektionsfraktion aufweisen. Das Risiko ist umso höher, je stärker die Pumpfunktion eingeschränkt ist.

Wie managen Sie die schmerzhafte diabetische Polyneuropathie?

10.05.2024 DDG-Jahrestagung 2024 Kongressbericht

Mit Capsaicin-Pflastern steht eine neue innovative Therapie bei schmerzhafter diabetischer Polyneuropathie zur Verfügung. Bei therapierefraktären Schmerzen stellt die Hochfrequenz-Rückenmarkstimulation eine adäquate Option dar.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.